Pediatric Sedation and Analgesia

Judy Zier, MD

Last updated 12/96 for content, 9/97 for format

 

Twenty, twenty, twenty-four hours ago
I wanna be sedated
Nothing to do nowhere to go
I wanna be sedated

the Ramones

Outline

 

Indications

Levels of Sedation

Conscious sedation

Deep sedation

General anesthesia

Sedation as a continuum

Each state of sedation carries the risk of the patient slipping into the next deeper level of sedation; therefore, if conscious sedation is used, must be prepared to manage a patient in deep sedation

Return to top

General guidelines - equipment

Must be appropriate for age and size of the patient

 

General guidelines - documentation

General guidelines - personnel

Return to top

Medications available

Local anesthetics

Analgesics - non-narcotic

Analgesics - narcotic

May cause respiratory depression, particularly when combined with a benzodiazepine; can be reversed with naloxone (Narcan) 0.01-0.1 mg/kg - however, half-life of naloxone may be shorter than that of the narcotic, making repeated doses necessary

Return to top

Sedatives - benzodiazepines

Relieve anxiety, provide sedation and amnesia; no analgesic properties; can be given orally, rectally or IV; respiratory and/or cardiovascular depression may occur, particularly with rapid administration; may be reversed with flumazenil 0.002-0.02 mg/kg; may cause agitation and hyperexcitability

Sedatives - barbiturates

CNS depression, from mild sedation to deep coma; no analgesic properties; may cause respiratory depression with loss of protective airway reflexes at higher doses; may cause cardiovascular depression

Sedatives - other

Other agents

Choose agents based on expectations of procedure

 

Use only drugs you have experience with and feel comfortable using

Return to top

Return to ACP index

 


This outline is meant for teaching purposes only, drug dosing should be confirmed by an appropriate resource (i.e. a Pharmacist, AHFS Red Book, PDR etc.). These durgs should not be used by inexperienced care givers.

Questions or comments regarding this out-line should be directed to the author at:

zierx001@maroon.tc.umn.edu

This page last updated 9/2/1997 at 1055CDT